Skip to main content
. Author manuscript; available in PMC: 2023 Aug 1.
Published in final edited form as: Eur J Heart Fail. 2022 May 22;24(8):1418–1426. doi: 10.1002/ejhf.2528

Table 1.

Baseline Characteristics of Patients with HF

Variable / Cohort UCSD UCSF Northwestern Medicine BIOSTAT-CHF CHARM-Alternative CHARM-Added PARADIGM-HF CHARM-Preserved TOPCAT
(n=4064) (n=1294) (n=5055) (n=884) (n=654) (n=922) (n=7970) (n=1060) (n=2559)
Age (years) 59.3 ± 13.3 57.4 ± 15.4 68.9 ± 15.3 65.2 ± 11.2 65.9 ± 11.5 63.8 ± 11.7 63.8 ± 11.4 66.1 ± 11.4 68.9 ± 9.7
Female (%) 57.7 58.8 53.6 72.3 32.3 22.9 22.0 43.2 50.7
LVEF (%) 55 ± 17 n/a 49 ± 17 29 ± 14 29 ± 8 27 ± 8 30 ± 6 55 ± 9 57 ± 11
Diastolic BP (mmHg) 70 ± 14 68 ± 13 70 ± 12 77 ± 15 75 ± 11 72 ± 10 74 ± 10 74 ± 11 75 ± 11
Creatinine (mg/dl) 1.0 [0.8–1.5] 1.2 [0.8–1.8] 1.1 [0.9–1.6] 1.1 [0.9–1.4] 1.1 [0.9–1.4] 1.1 [0.9–1.3] 1.1 [0.9–1.3] 1.0 [0.8–1.3] 1.1 [0.9–1.3]
Blood urea nitrogen (mg/dl) 19.2 [13.2–29.0] 21.6 [14.5–35.8] 21.6 [15.2–31.6] 22.0 [14.6–34.2] 21.0 [16.0–29.4] 21.0 [16.0–27.0] 19.0 [15.0–24.0] 20.0 [15.7–26.6] 19.0 [14.8–25.2]
Albumin (g/dl) 3.6 ± 0.7 3.2 ± 0.7 3.7 ± 0.6 3.2 ± 0.9 - - 4.3 ± 0.3 - 4.1 ± 0.5
White blood cell count (x103/l) 8.4 [6.2–11.5] 8.0 [6.1–11.0] 7.2 [5.6–9.1] 7.9 [6.4–9.6] 7.0 [5.9–8.4] 7.1 [5.8–8.6] 6.7 [5.6–8.1] 7.0 [5.8–8.4] 6.7 [5.6–8.0]
Hemoglobin (g/dl) 11.3 ± 2.6 11.6 ± 2.4 11.7 ± 2.1 13.3 ± 2.0 13.5 ± 1.7 13.8 ± 1.6 13.9 ± 1.6 13.4 ± 1.6 13.1 ± 1.7
RDW (%) 14.8 [13.7–16.5] - 15.2 [14.0–16.8] - 14.5 [13.6–15.7] 14.3 [13.5–15.3] - 14.3 [13.4–15.4] -
Platelets (x103/l) 204 [143–272] 194 [135–258] 223 [173–285] 221 [181–265] 223 [184–266] 217 [180–259] 193 [161–230] 227 [189–274] 222 [190–260]
MARKER-HF −0.14 ± 0.20 −0.06 ± 0.19 −0.19 ± 0.16 −0.17 ± 0.17 −0.25 ± 0.08 −0.24 ± 0.08 −0.33 ± 0.07 −0.26 ± 0.08 −0.29 ± 0.11

Values reported as: Mean ± SD for normally distributed variables or as median and [IQR] for the others.